Cure CEO Seema Kumar sits down with Alex Zhavoronkov, Ph.D., Chairman and CEO of Insilico Medicine, who will discuss how generative AI is being used to transform and accelerate drug discovery, particularly for diseases related to aging, plus exciting news about its latest deal with Exelixis to develop novel drugs for BRCA-mutant tumors – found in breast, ovarian, pancreatic and prostate cancers.
Register Here and Tune-In on October 17 at 9:30 a.m. Pacific time to watch this very exciting talk on how AI is changing the game in medicine.